Clinical trialNCT01057810CompletedPhase 3Interventional

Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer

SponsorBristol-Myers SquibbEnrollment837Prostate Cancer

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Bristol-Myers Squibb
Bristol-Myers Squibb
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

134 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Argentina

Local Institution
Buenos Aires, Buenos Aires, Argentina
Local Institution
Buenos Aires, Buenos Aires, Argentina
Local Institution
Buenos Aires, Buenos Aires, Argentina
Local Institution
Córdoba, Córdoba Province, Argentina
Local Institution
La Rioja, La Rioja Province, Argentina
Local Institution
Rosario, Santa Fe Province, Argentina
Local Institution
Rosario, Santa Fe Province, Argentina

Australia

Local Institution
Kogarah, New South Wales, Australia
Local Institution
Ashford, South Australia, Australia
Local Institution
Box Hill, Victoria, Australia
Local Institution
East Bentleigh, Victoria, Australia
Local Institution
Frankston, Victoria, Australia
Local Institution
Heidelberg, Victoria, Australia
Local Institution
Subiaco, Western Australia, Australia

Brazil

Local Institution
Brasília, Federal District, Brazil
Local Institution
Belo Horizonte, Minas Gerais, Brazil
Local Institution
Belo Horizonte - Mg, Minas Gerais, Brazil
Local Institution
Ijuí, Rio Grande do Sul, Brazil
Local Institution
Porto Alegre, Rio Grande do Sul, Brazil

Canada

Local Institution
Kingston, Ontario, Canada
Local Institution
Montreal, Quebec, Canada
Local Institution
Québec, Quebec, Canada

Chile

Local Institution
Temuco, Araucania, Chile
Local Institution
Viña del Mar, Valparaiso, Chile
Local Institution
Santiago, Chile

Colombia

Local Institution
Montería, Departamento de Córdoba, Colombia
Local Institution
Bogotá, Colombia
Local Institution
Bucaramanga, Colombia
Local Institution
Medellín, Colombia

Czechia

Local Institution
Hradec Králové, Czechia
Local Institution
Liberec, Czechia
Local Institution
Prague, Czechia
Local Institution
Prague, Czechia

Denmark

Local Institution
Herlev, Denmark
Local Institution
København Ø, Denmark

France

Local Institution
Bordeaux, France
Local Institution
Clermont-Ferrand, France
Local Institution
Marseille, France
Local Institution
Pointe à Pitre, France
Local Institution
Poitiers, France

94 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Jul 2010
Primary completion: 30 Apr 2015
Completion: 31 Jul 2015
Last update posted: 18 Aug 2016
Registered enrollment: 837
Registry id: NCT01057810

Cross-registrations

EU-CTR / CTIS (EudraCT)2009-016217-23

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.